These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24061412)

  • 21. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
    Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
    Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL; Cheng MH; Chao HT; Wang PH
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lowering your breast cancer risk. A daily pill can hold the key to prevention for some women.
    Johns Hopkins Med Lett Health After 50; 2014 Feb; 25(15):1-2. PubMed ID: 25118364
    [No Abstract]   [Full Text] [Related]  

  • 25. Preventing breast cancer in high-risk women, 2008.
    Vogel VG
    Oncology (Williston Park); 2008 May; 22(6):666-73; discussion 679, 682, 684. PubMed ID: 18561555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endocrine prevention of breast cancer.
    Howell A
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):615-23. PubMed ID: 18971122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).
    Powles TJ
    Breast Cancer Res; 2006; 8(5):111. PubMed ID: 17049068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should We Offer Medication to Reduce Breast Cancer Risk?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Burns RB; Schonberg MA; Tung NM; Libman H
    Ann Intern Med; 2016 Aug; 165(3):194-204. PubMed ID: 27479221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.
    Nelson HD; Smith ME; Griffin JC; Fu R
    Ann Intern Med; 2013 Apr; 158(8):604-14. PubMed ID: 23588749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention in postmenopausal women.
    Rastogi P
    Menopause; 2008; 15(4 Suppl):810-5. PubMed ID: 18596603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Additional effect of SERM: mammary gland].
    Kurebayashi J
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone builder vs. breast cancer.
    Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
    [No Abstract]   [Full Text] [Related]  

  • 36. [Breast cancer chemoprevention. Rational, trials results and future].
    Cutuli B; Lesur A; Namer M; Kerbrat P
    Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA; Moraghan TJ; Perez EA
    Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective estrogen-receptor modulators for primary prevention of breast cancer.
    Fabian CJ; Kimler BF
    J Clin Oncol; 2005 Mar; 23(8):1644-55. PubMed ID: 15755972
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of hormone-related cancers: breast cancer.
    Dunn BK; Wickerham DL; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two good choices to prevent breast cancer: great taste, less filling.
    Hortobagyi GN; Brown PH
    Cancer Prev Res (Phila); 2010 Jun; 3(6):681-5. PubMed ID: 20522797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.